Nuvilex (NASDAQ:PMCB) Shares Cross Below 50 Day Moving Average – What’s Next?

Nuvilex Inc. (NASDAQ:PMCB) crossed below its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.40 and traded as low as $0.2469. Nuvilex shares last traded at $0.3990, with a volume of 1,268,048 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded Nuvilex from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, September 2nd. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Nuvilex currently has a consensus rating of “Sell”.

Nuvilex Price Performance

The firm has a 50-day moving average of $0.40 and a 200-day moving average of $0.62. The stock has a market cap of $4.28 million, a PE ratio of -0.17 and a beta of 0.78.

Nuvilex (NASDAQ:PMCB) last released its quarterly earnings data on Monday, September 14th. The company reported ($0.54) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.48).

Nuvilex Company Profile

Nuvilex, Inc. was a biotechnology company that later changed its name to PharmaCyte Biotech, Inc. and continued to trade under the ticker symbol PMCB. The company focused on developing cellular therapies intended to treat serious diseases, particularly cancer and diabetes. Its primary technology involved encapsulating genetically engineered human cells in proprietary cellulose-based capsules. These cells were designed to produce therapeutic substances inside the body while limiting exposure to healthy tissue.